- Senior Investigator, Laboratory of Genitourinary Cancer Pathogenesis
Dr. Kelly received her Ph.D. from the University of California, Irvine. She completed her postdoctoral training in the laboratory of Philip Leder, Harvard Medical School, and she has maintained an independent research program at the NCI since 1984. Dr. Kelly's interests have focused on the genetic regulation of cell growth, cancer progression and metastasis.
- (2013). CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model. ONCOGENE. 32(22), 2726-2738.
- (2012). Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor beta-Initiated Prostate Cancer Epithelial-Mesenchymal Transition. MOLECULAR AND CELLULAR BIOLOGY. 32(5), 941-953.
- (2011). LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells. CANCER RESEARCH. 71(23), 7301-7311.
- (2011). Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal Transition. AMERICAN JOURNAL OF PATHOLOGY. 179(1), 422-435.
- (2010). Characterizing the Contribution of Stem/Progenitor Cells to Tumorigenesis in the Pten(-/-) TP53(-/-) Prostate Cancer Model. STEM CELLS. 28(12), 2129-2140.